Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology-Reference-Cited by-同舟云学术

Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology

Published:2015-05-25 Issue:8 Volume:41 Page:1161-1168
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Murakami Maki¹²,Kobayashi Takao³²⁴,Kubo Takahiko⁵²,Hata Toshiyuki²⁶,Takeda Satoru⁷²,Masuzaki Hideaki²⁸

Affiliation:

1. Department of Obstetrics and Gynecology; Aiwa Hospital; Kawagoe Saitama

2. Perinatology Committee; Japan Society of Obstetrics and Gynecology; Tokyo

3. Department of Obstetrics and Gynecology; Hamamatsu Medical Center; Hamamatsu

4. Japan Society of Obstetrical; Gynecological and Neonatal Hematology; Fukuoka Japan

5. Division of Obstetrics, Center of Maternal-Fetal, Neonatal and Reproductive Medicine; National Center for Child Health and Development

6. Department of Perinatology and Gynecology; Kagawa University Graduate School of Medicine; Miki

7. Department of Obstetrics and Gynecology; Juntendo University Faculty of Medicine

8. Department of Obstetrics and Gynecology; Nagasaki University Faculty of Medicine; Nagasaki

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.12712/fullpdf

Reference16 articles.

1. Japan Association of Obstetricians and Gynecologists Japanese Maternal Death Registration investigated by Japan Association of Obstetricians and Gynecologists 2010-2012 http://www.jaog.or.jp/all/document/67_130710.pdf

2. Japan Society of Obstetrics and Gynecology Japan Association of Obstetricians and Gynecologists Japan Society of Perinatal and Neonatal Medicine Japanese Society of Anesthesiologists The Japan Society of Transfusion Medicine and Cell Therapy Clinical Guideline for Critical Bleeding in Obstetrics 2010 www.jspnm.com/topics/data/topics100414.pdf

3. Recombinant activated factor VII in obstetric hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry;Phillips;Anesth Analg,2009

4. Use of recombinant activated factor VII in primary postpartum hemorrhage: The Northern European registry 2000-2004;Alfirevic;Obstet Gynecol,2007

5. Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry: A multicentric observational retrospective study;Barillari;Thromb Res,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis;Research and Practice in Thrombosis and Haemostasis;2024-07

2. Amniotic Fluid Embolism: A Narrative Review;Journal of Obstetric Anaesthesia and Critical Care;2023-07

3. Review of Current Insights and Therapeutic Approaches for the Treatment of Refractory Postpartum Hemorrhage;International Journal of Women's Health;2023-06

4. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care;European Journal of Anaesthesiology;2023-04

5. Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort study;International Journal of Hematology;2021-03-12